|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1997-8-8
|
|
pubmed:abstractText |
L4-L5 intertransverse process fusions were produced with 58 micrograms, 230 micrograms, or 920 micrograms of recombinant human bone morphogenetic protein-2 in 20 dogs. Eleven had traditional decortication of posterior elements before insertion of the implant. Nine were left undecorticated. All animals were evaluated 3 months after surgery.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0362-2436
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1171-80
|
|
pubmed:dateRevised |
2009-7-9
|
|
pubmed:meshHeading |
pubmed-meshheading:9201852-Animals,
pubmed-meshheading:9201852-Bone Morphogenetic Protein 2,
pubmed-meshheading:9201852-Bone Morphogenetic Proteins,
pubmed-meshheading:9201852-Bone Regeneration,
pubmed-meshheading:9201852-Dogs,
pubmed-meshheading:9201852-Female,
pubmed-meshheading:9201852-Humans,
pubmed-meshheading:9201852-Lumbar Vertebrae,
pubmed-meshheading:9201852-Recombinant Proteins,
pubmed-meshheading:9201852-Spinal Fusion,
pubmed-meshheading:9201852-Stress, Mechanical,
pubmed-meshheading:9201852-Transforming Growth Factor beta
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements.
|
|
pubmed:affiliation |
Department of Orthopaedic Surgery, UCLA School of Medicine, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
